Back
Speaker illustration

Doctor Thomas Fretz

Indiana University School of Medicine, Indianapolis (United States of America)

Member of:

European Society of Cardiology

Presentations

Factors associated with the development of premature ventricular complex induced cardiomyopathy

Event: ESC Congress 2025

Topic: Risk Factors and Risk Assessment

Session: Targeting premature ventricular complexes: what matters

Access
Like
Thumbnail

Choice of monotherapy following short duration of dual-antiplatelet therapy after percutaneous coronary intervention: a meta-analysis of randomized clinical trials

Event: ESC Congress 2025

Topic: Pharmacotherapy

Session: Pharmacotherapy to improve outcomes in coronary disease

Access
Like
Thumbnail

A shorter duration of dual-antiplatelet therapy following percutaneous coronary intervention by region of study: a meta-analysis of randomized clinical trials

Event: ESC Congress 2025

Topic: Epidemiology, Prognosis, Outcome

Session: Pharmacotherapy in acute coronary syndromes (3)

Access
Like
Thumbnail

Characteristics of ejection fraction recovery after premature ventricular complex ablation

Event: ESC Congress 2025

Topic: Catheter Ablation of Arrhythmias

Session: What is hot in ventricular arrhythmias

Access
Like
Thumbnail

Impact of colchicine on atrial fibrillation recurrence following pulmonary vein isolation

Event: ESC Congress 2025

Topic: Rhythm Control, Hybrid Therapy

Session: Catheter ablation in atrial fibrillation (2)

Access
Like
Thumbnail

Efficacy and safety of natriuresis-guided diuresis in acute decompensated heart failure: a meta-analysis

Event: ESC Congress 2025

Topic: Pharmacotherapy

Session: Challenges and strategies in heart failure care

Access
Like
Thumbnail

The challenge of implanting a cardioverter-defibrillator in andersen tawil syndrome despite the life-threatening arrhythmic phenotype.

Event: ESC Congress 2025

Topic: Implantable Cardioverter-Defibrillator (ICD)

Session: Device therapy: a 360° view

Access
Like
Thumbnail

A shorter duration of dual-antiplatelet therapy following percutaneous coronary intervention: a meta-analysis of randomized clinical trials

Event: ESC Congress 2025

Topic: Adjunctive Pharmacotherapy

Session: Adjunctive antiplatelet therapy for patients undergoing percutaneous coronary intervention

Access
Like
Thumbnail

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources